Skip to main content

Russia sanctions, vaccine worries, NBR turns hawkish

Comments from US President Joe Biden this week threatening to take a tougher stance against Russia have raised the prospect of tighter US sanctions that could deal a significant blow to Russian markets. Meanwhile, although dismissed by the medical community, fears that the AstraZeneca vaccine could be associated with blood clotting may add to vaccine hesitancy in the region. This potential obstacle adds to a worsening situation on the virus front. Finally, hawkish comments from Romania’s central bank has prompted us to take out the rate cut that we had previously expected in April.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.